Annals of Surgical Oncology

, Volume 13, Issue 12, pp 1569–1578 | Cite as

Clinical Implications of Combined Portal Vein Resection as a Palliative Procedure in Patients Undergoing Pancreaticoduodenectomy for Pancreatic Head Carcinoma

  • Kazuaki Shimada
  • Tsuyoshi Sano
  • Yoshihiro Sakamoto
  • Tomoo Kosuge



The clinical implications of combined portal vein resections are controversial.


One-hundred and forty-nine consecutive patients underwent macroscopically curative pancreatectomies for pancreatic head carcinoma between January 1, 1996 and December 31, 2004. Portal vein resection was performed in 86 patients (58%). Data on surgical mortality, morbidity, perioperative outcome, pathological factors, initial recurrence site, and survival were retrospectively compared between the patients with and without portal vein resection.


The incidence of postoperative pancreatic fistula was lower among patients who underwent portal vein resection. The median survival period was 14 months for the portal vein resection group and 35 months for the non-portal vein resection group, respectively. Combined portal vein resection was a significant predictor of poor survival using a multivariate analysis. Portal vein resection was strongly associated with larger tumor size, the degree of retropancreatic tissue invasion, the presence of extrapancreatic nerve plexus invasion, lymph node metastases, and positive cancer infiltration at the surgical margins.


Portal vein resection at the time of pancreaticoduodenectomy can be safely performed. However, most of patients requiring portal vein resection do not achieve a potentially curative resection or a favorable survival term. As a result, the aggressive application and the strict selection of portal vein resection might reduce the incidence of positive surgical margins, enabling long-term survival in patients who do not require portal vein resection.


Pancreatic cancer Portal vein resection Predictive factors Recurrence pattern Postoperative complications 


  1. 1.
    Warshaw AL, Castillo CF. Pancreatic carcinoma. N Engl J Med 1992; 326: 455–465PubMedCrossRefGoogle Scholar
  2. 2.
    Nitecki SS, Sarr MG, Colby TV, Heerden JA. Long-term survival after resection for ductal adenocarcinoma of the pancreas: is it really improving? Ann Surg 1995; 221: 59–66PubMedCrossRefGoogle Scholar
  3. 3.
    Ishikawa O, Ohigashi H, Imaoka S, et al. Preoperative indications for extended pancreatectomy for locally advanced pancreas cancer involving the portal vein. Ann Surg 1992; 215: 231–236PubMedCrossRefGoogle Scholar
  4. 4.
    Fuhrman GM, Charnsangavej C, Abbruzzese JL, et al. Thin-section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms. Am J Surg 1994; 167: 104–113PubMedCrossRefGoogle Scholar
  5. 5.
    Furukawa H, Kosuge T, Mukai K, et al. Helical computed tomography in the diagnosis of portal vein invasion by pancreatic head carcinoma. Arch Surg 1998; 133: 61–65PubMedCrossRefGoogle Scholar
  6. 6.
    Takahashi S, Ogata Y, Tsuzuki T. Combined resection of the pancreas and portal vein for pancreatic cancer. Br J Surg 1994; 81: 1190–1193PubMedGoogle Scholar
  7. 7.
    Nakao A, Harada A, Nonami T, Kaneko T, Inoue S, Takagi H. Clinical significance of portal invasion by pancreatic head carcinoma. Surgery 1995; 117: 50–55PubMedCrossRefGoogle Scholar
  8. 8.
    Harrison LE, Klimstra DS, Brennan MF. Isolated portal vein involvement in pancreatic adenocarcinoma. A contraindication for resection? Ann Surg 1996; 224: 342–349PubMedCrossRefGoogle Scholar
  9. 9.
    Leach SD, Lee JE, Charnsangavej C, et al. Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head. Br J Surg 1998; 85: 611–617PubMedCrossRefGoogle Scholar
  10. 10.
    Bachellier P, Nakano H, Oussoultzoglou E, et al. Is pancreaticoduodenectomy with mesentericoportal venous resection safe and worthwhile? Am J Surg 2001; 182: 120–129PubMedCrossRefGoogle Scholar
  11. 11.
    Hartel M, Niedergethmann M, Farag-Soliman M, et al. Benefit of venous resection for ductal adenocarcinoma of the pancreatic head. Eur J Surg 2002; 168: 707–12PubMedCrossRefGoogle Scholar
  12. 12.
    Nakaghori T, Kinoshita T, Konishi M, et al. Survival benefits of portal vein resection for pancreatic cancer Am J Surg 2003;186: 149–153CrossRefGoogle Scholar
  13. 13.
    Fuhrman GM, Leach SD, Staley CA, et al. Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Ann Surg 1996; 223: 154–162PubMedCrossRefGoogle Scholar
  14. 14.
    Tseng JF, Raut CP, Lee JE, et al. Pancreatoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg 2004; 8: 935–49PubMedCrossRefGoogle Scholar
  15. 15.
    Roder JD, Stein HJ, Siewert JR. Carcinoma of the periampullary region: who benefits from portal vein resection? Am J Surg 1996; 171: 170–175PubMedCrossRefGoogle Scholar
  16. 16.
    Launois B, Stasik C, Bardaxoglou E, et al. Who benefits from portal vein resection during pancreaticoduodenectomy for pancreatic cancer? World J Surg 1999; 23: 926–929PubMedCrossRefGoogle Scholar
  17. 17.
    Geenen RC, Kate FJ, Wit LT, et al. Segmental resection and wedge excision of the portal or superior mesenteric vein during pancreatoduodenectomy. Surgery 2001; 129: 158–163PubMedCrossRefGoogle Scholar
  18. 18.
    Yachida S, Fukushima N, Sakamoto M, Matsuno T, Kosuge T, Hirohashi S. Implications of peritoneal washing cytology in patients with potentially respectable pancreatic cancer. Br J Surg 2002; 89: 573–578PubMedCrossRefGoogle Scholar
  19. 19.
    Ozaki H, Kinoshita H, Kosuge T, et al. Long-term survival after multimodality treatment for resectable pancreatic cancer. Int J Pancteatol 2000; 27: 217–224CrossRefGoogle Scholar
  20. 20.
    Shimada K, Sano T, Sakamoto Y, Kosuge T. Safe management of the pancreatic remnant with prolamine duct occlusion after extended pancreaticoduodenectomy. Hepatogastroenterology 2005; 52:1872–7Google Scholar
  21. 21.
    Japan Pancreas Society. (1996) Classification of pancreatic cancer, 1st Engl edn. Tokyo: KaneharaGoogle Scholar
  22. 22.
    Sobin LH, Wittekind Ch. (2002) TNM Classification of Malignant tumors, 6th ed. New York, NY: JohnWiley & Sons Inc.Google Scholar
  23. 23.
    Hamanaka Y, Nishihama K, Hamasaki T, et al. Pancreatic juice output after pancreatoduodenectomy in relation to pancreatic consistency, duct size, and leakage. Surgery 1996; 119: 281–287PubMedCrossRefGoogle Scholar
  24. 24.
    Ishikawa O, Ohhigashi H, Sasaki Y, et al. Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head. Ann Surg 1988; 208: 215–220PubMedCrossRefGoogle Scholar
  25. 25.
    Lϋttges J, Vogel I, Menke M, Henne-Bruns D, Kremer B,Klöppel G. The retroperitoneal resection margin and vessel involvement are important factors determining survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas. Virchows Arch 1998; 433: 237–242PubMedCrossRefGoogle Scholar
  26. 26.
    Nagai H, Koroda A, Morioka Y. Lymphatic and local spread of T1 and T2 pancreatic cancer. A study of autopsy material. Ann Surg 1986; 204: 65–71PubMedCrossRefGoogle Scholar
  27. 27.
    Ishikawa O, Ohigashi H, Sasaki Y, et al. Intraoperative cytodiagnosis for detecting a minute invasion of the portal vein during pancreaticoduodenectomy for adenocarcinoma of the pancreatic head. Am J Surg 1998; 175: 477–481PubMedCrossRefGoogle Scholar
  28. 28.
    Nakao A, Kaneko T. Intravascular ultrasonography for assessment of portal vein invasion by pancreatic carcinoma. World J Surg 1999; 23:892–5PubMedCrossRefGoogle Scholar
  29. 29.
    Yamaue H, Tani M, Onishi H, et al. Locoregional chemotherapy for patients with pancreatic cancer intra-arterial adjuvant chemotherapy after pancreatectomy with portal vein resection. Pancreas 2002; 25: 366–372PubMedCrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2006

Authors and Affiliations

  • Kazuaki Shimada
    • 1
  • Tsuyoshi Sano
    • 1
  • Yoshihiro Sakamoto
    • 1
  • Tomoo Kosuge
    • 1
  1. 1.Department of Hepatobiliary and Pancreatic SurgeryNational Cancer Center HospitalTokyoJapan

Personalised recommendations